Soliqua 100/33 33 ug/mL (Insulin Glargine and Lixisenatide INJECTION, SOLUTION) 33 ug/mL

Soliqua 100/33 is a combination of insulin glargine and lixisenatide, designed for subcutaneous administration. This medication is used to manage blood sugar levels in adults with type 2 diabetes. It combines long-acting insulin with a GLP-1 receptor agonist for comprehensive diabetes care.

Strength

33 ug/mL

Pack Size

1 SYRINGE in 1 CARTON (0024-5761-01) / 3 mL in 1 SYRINGE

Manufacturer / TM Owner

Sanofi-Aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Soliqua 100/33 is primarily used for the management of type 2 diabetes in adults. This medication works by combining insulin glargine, which provides a steady release of insulin over 24 hours, with lixisenatide, a GLP-1 receptor agonist that helps lower blood sugar levels by increasing insulin secretion and reducing glucagon release. People often ask, 'What is Soliqua 100/33 used for?' It is typically prescribed for individuals who require both types of medication to achieve better glycemic control.

Side Effects

Common effects of Soliqua 100/33 may include nausea, vomiting, diarrhea, and injection site reactions. Some users might experience hypoglycemia, or low blood sugar, especially if meals are skipped or if the dosage is not adjusted properly. It is important to monitor blood sugar levels regularly while using this medication.

Precautions & Warnings

Soliqua 100/33 should be handled with care and stored as directed to maintain its efficacy. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always check the label and expiration date before use.

Avoid Interactions

Soliqua 100/33 may interact with other medications, including those that affect blood sugar levels, such as oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. It is advisable to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Soliqua 100/33 is used to manage blood sugar levels in adults with type 2 diabetes. It combines insulin glargine and lixisenatide to provide comprehensive diabetes care.

Soliqua 100/33 is administered subcutaneously, typically in the abdomen, thigh, or upper arm. The specific administration instructions should be followed as directed by a healthcare professional.

Common side effects may include nausea, vomiting, diarrhea, and injection site reactions. Hypoglycemia can also occur, especially if meals are skipped or dosage is not adjusted properly.

Soliqua 100/33 may interact with other medications that affect blood sugar levels. It is important to consult a healthcare provider before combining it with other diabetes treatments.

Soliqua 100/33 should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C) and protected from light. It should not be frozen and should be kept away from direct heat and sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.